Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin for the Treatment of Non-Muscle-Invasive Bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the BladderJ Urol 2020 Aug 01;204(2)247-253, GJ DeCastro, W Sui, JS Pak, SM Lee, D Holder, MM Kates, RK Virk, CG Drake, CB Anderson, B James, CT Abate-Shen, JM McKiernan
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.